| Old Articles: <Older 251-260 Newer> |
 |
BusinessWeek October 6, 2003 Robert Barker |
Don't Get Hooked on Applied Materials The rush of pleasure promised by chip stocks can be so intense that it's understandable why some investors, after so recently having endured the agony of withdrawal, are now back to cravings. As an example of semiconductor investing's two sides, there's no better stock than Applied Materials.  |
BusinessWeek October 6, 2003 Robert Barker |
A Better Way to Size Up a Company Forget p-e ratios. "Enterprise value" can give you a clearer picture  |
BusinessWeek October 6, 2003 Gene G. Marcial |
A Glow at Yankee Candle Yankee Candle is not the sort of stock that large-cap value player John Maloney usually goes for. But after a closer look, the president of M&R Capital Management saw the light: In recent weeks he bought 200,000 shares of the small-cap growth company, which operates 278 stores.  |
BusinessWeek October 6, 2003 Gene G. Marcial |
Dendreon: New Weapons against Tumors What's so hot about Dendreon, which leaped from 3 last year to 9.25 on Sept. 24? The little-known biotech develops immunologically based cancer remedies, and its lead product, Provenge, is aimed at prostate cancer.  |
BusinessWeek October 6, 2003 Gene G. Marcial |
Sweet Licensing Deals for Acacia Acacia Technologies Group could be a big beneficiary of the popularity of video-on-demand -- movies provided for a fee by hotels and on cable TV. So says Paul Sethi of Vertical Ventures Investments, who thinks the shares could double in a year.  |
Entrepreneur October 2003 Julie Monahan |
Up in the Air Dotcom stocks could be poised for a comeback.  |
BusinessWeek September 29, 2003 Robert Barker |
An Antidote for Inflation Anxiety Given a growing inflationary danger, it's only prudent to consider lightening up on bonds. Yet if you depend on interest payments from bonds to cover part of your living expenses, you will need to generate income from your portfolio in other ways.  |
BusinessWeek September 29, 2003 Gene G. Marcial |
Taking Aim at Cancer Cell Therapeutics isn't expected to make money until 2007, but Edward Hemmelgarn, president of Shaker Investments, is buying into the small-cap biotech anyway. Shaker already owns 1.7 million shares. Cell is developing cancer treatments that are less toxic but more effective, he says.  |
BusinessWeek September 29, 2003 Gene G. Marcial |
Landry's Restaurants: Riches from the Sea Landry's Restaurants, No. 2 in seafood, owns 279 restaurants, such as Joe's Crab Shack and Landry's Seafood House. Its stock is heating up -- from 15 in March to 22 on Sept. 17. Star stock-picker Roger Lipton sees it hitting 30 in a year.  |
BusinessWeek September 29, 2003 |
Perficient Dishes Out Efficient Tech Help When the tech bubble burst, little-known Perficient tumbled -- from 28 in 2000 to 1.70 now. But Perficient, which helps giants like IBM adapt their software to customers, may get a boost as IT spending rebounds.  |
| <Older 251-260 Newer> Return to current articles. |